Japan’s Daiichi Sankyo halts trials of existing drug for COVID-19 treatment

Japan’s Daiichi Sankyo Co 4568.T said on Tuesday it was halting development of an existing drug for the treatment of COVID-19. Daiichi Sankyo in March started a clinical trial in Japan of an inhaled …
( read original story …)

---